Skip to main content

Table 3 Sensitivity Analysis: Adjusted odds of four outcomes among persons age < 65 (ICD9 516.3 or 515)a

From: Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample

 

Lung Transplant

Death

Rehabilitation Transferb

VATS Biopsy

Odds Ratio (95% CI)

P-Value

Odds Ratio (95% CI)

P-Value

Odds Ratio (95% CI)

P-Value

Odds Ratio (95% CI)

P-Value

Insurance

 Non-medicaid

Reference

Reference

 

Reference

 

Reference

 

 Medicaid

0.28 (0.15, 0.51)

< 0.001

0.96 (0.82, 1.12)

0.57

0.78 (0.44, 1.38)

0.39

0.43 (0.32, 0.56)

< 0.001

 Uninsured

0.20 (0.06, 0.63)

0.01

0.84 (0.66, 1.08)

0.18

0.45 (0.16, 1.25)

0.12

0.50 (0.34, 0.75)

< 0.01

ZIP Income Quartile

 Quartile 1

0.50 (0.34, 0.72)

< 0.001

0.96 (0.81, 1.13)

0.60

1.04 (0.53, 2.04)

0.91

1.29 (0.97, 1.73)

0.08

 Quartile 2

0.63 (0.47, 0.84)

<.01

0.87 (0.74, 1.02)

0.08

1.30 (0.73, 2.31)

0.38

1.14 (0.88, 1.49)

0.32

 Quartile 3

0.81 (0.64, 1.03)

0.09

0.96 (0.82, 1.12)

0.57

1.24 (0.69, 2.22)

0.47

1.05 (0.81, 1.36)

0.74

 Quartile 4 (Highest)

Reference

 

Reference

 

Reference

 

Reference

 
  1. aAnalyses of death, rehab, and VATS were adjusted for age, race, gender, insurance, year, zip income quartile, hospital region, hospital location, hospital teaching status, hospital bedsize, and AHRQ Elixhauser Comorbidity index for in-hospital mortality. Analyses of lung transplantation were adjusted for these same variables, but not hospital teaching status and urban/rural location, because the proportion of lung transplantations exhibiting these characteristics was either 0% or 100%
  2. bThe analysis for rehabilitation transfer demonstrated questionable model fit